Related Experiment Videos

Cardiovascular and oral disease interactions: what is the evidence?

Pauline J Ford1, Kazuhisa Yamazaki, Gregory J Seymour

  • 1Oral Biology and Pathology, School of Dentistry, University of Queensland, Brisbane, Australia. p.ford@uq.edu.au

Insights

Periodontal disease, an oral infection, is linked to increased cardiovascular disease risk. Minimizing oral disease may significantly benefit heart health by reducing inflammation and infection pathways.

Area of Science:

  • Oral health
  • Cardiovascular medicine
  • Immunology

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality, primarily driven by atherosclerosis.
  • Infection and inflammation are increasingly recognized as critical factors in the development of atherosclerosis (atherogenesis).
  • Periodontal disease, a common chronic oral infection, has been associated with higher risks of stroke and coronary heart disease.

Purpose of the Study:

  • To review the evidence linking oral disease, specifically periodontal infections, with cardiovascular disease.
  • To explore proposed pathogenic mechanisms underlying this association.
  • To evaluate the role of immune responses, including autoimmunity, in the context of oral infections and atherosclerosis.

Main Methods:

  • Literature review of studies investigating the association between periodontal disease and cardiovascular outcomes.
  • Analysis of proposed etiological hypotheses, including common susceptibility, systemic inflammation, direct infection, and molecular mimicry.
  • Examination of research on heat shock proteins (HSPs) and autoimmune responses in atherosclerosis.

Main Results:

  • Strong evidence suggests infection and inflammation are significant risk factors for atherosclerotic cardiovascular disease.
  • Several hypotheses explain the link, with molecular mimicry involving bacterial heat shock proteins (HSPs) offering a potential autoimmune mechanism.
  • Endothelial cells and circulating T cells in atherosclerosis patients show expression and reactivity related to HSPs.

Conclusions:

  • Atherosclerotic cardiovascular disease is multifactorial, but oral infections represent a significant, modifiable risk factor.
  • Minimizing oral disease is crucial for improving cardiovascular health.
  • Oral health professionals can play a vital role in enhancing patients' overall systemic health.

Related Concept Videos

The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...